GlaxoSmithKline CR`s Current Liabilities reached 201 CZK mil in 2017. This is 13.3 % less than in the previous year.
Buy Current Liabilities data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 55.7 | 59.2 | 51.8 | 59.7 | 92.9 | ||||||||
| Bayer Czech Republic | CZK mil | ... | ... | ... | 306 | 280 | 410 | 426 | 522 | ||||||||||
| GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 1,747 | 990 | 943 | 656 | 713 | ||||||||||
| Merck Czech Republic | CZK mil | ... | ... | 196 | 187 | 200 | 91.9 | 78.7 | |||||||||||
| Novartis Czech Republic | CZK mil | 1,154 | 1,205 | 1,147 | 1,203 | 1,380 | |||||||||||||
| Pfizer Czech Republic | CZK mil | ... | ... | 1,835 | 1,474 | 1,226 | 1,212 | 742 | |||||||||||
| Roche Czech Republic | CZK mil | ... | ... | ... | 1,163 | 1,231 | 978 | 1,168 | 1,333 | ... | |||||||||
| Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 2,470 | 2,603 | 1,887 | 1,602 | 1,838 | |||||||||
| Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 48.2 | 59.1 | 186 | 203 | ||
| Walmark | CZK mil | ... | ... | ... | 558 | 395 | 559 | 735 | 1,629 |
Helgi Library 
